Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0640

0.0%

Nov 7 3:22 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mark Buczynski who wrote (12754)	3/27/2014 10:25:43 AM
From: Sam1832	of 13111

Of the three who decided to exercise their options and buy stock, only Wachter did so prior to the expiration date, which is usually a very good sign. If you look closely at the filings for Culpepper and Scott, however, they only decided to exercise on the last possible date (02/26/14) before the options expired, which doesn't mean all that much. They were in a "use them or lose them" situation. Here are links to the Form 4's: sec.gov sec.gov Thus, Wachter's action is a positive, while Culpepper's and Scott's were neutral/expected. Given that the latter two were granted these options exactly 10 years prior, it looks like they were part of a company grant program back then. I'm guessing Dees was also granted options on that date, so why didn't Craig also exercise his options?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next